List of Publications - January 2015

Prof. Ezzeldin Ibrahim – (January 2015) EMI
Page | 1
Prof. Ezzeldin Ibrahim, MD, FRCP, MSc
Chief Medical Officer
Executive Director of Research Center
Director, Oncology Center of Excellence
International Medical Center
Publications

Page | 2
Google Scholar Citations
As of October 2014

Page | 3
List of Publications
[1-179]
[180]
1. Klimo, P. and E. Ibrahim, Anaphylactic reaction to methotrexate used in high doses as an
adjuvant treatment of osteogenic sarcoma. Cancer Treat Rep, 1981. 65(7-8): p. 725.
2. Leahy, M.F., E.M. Ibrahim and A.J. Worth, Primary hepatic lymphoma: Two case reports and a
review of the literature. Medical and pediatric oncology, 1982. 10(6): p. 575-581.
3. Ibrahim, A., E. Ibrahim, N. Mitry, A. Abdul-Satir and A. Kuppa, Spinal cord compression due to
intrathoracic extramedullary haematopoiesis in homozygous thalassaemia. Journal of
Neurology, Neurosurgery & Psychiatry, 1983. 46(8): p. 780-782.
4. Ibrahim, A.W., E.M. Ibrahim, N.M. Mitry, A. Abdul-Satir and A. Kuppa, Spinal cord compression
due to intrathoracic extramedullary haematopoiesis in homozygous thalassaemia. J Neurol
Neurosurg Psychiatry, 1983. 46(8): p. 780-782.
5. Silver, H.K., E.M. Ibrahim, J.A. Evers, J.W. Thomas, R.N. Murray and J.J. Spinelli, Adjuvant BCG
immunotherapy for stage I and II malignant melanoma. Can Med Assoc J, 1983. 128(11): p.
1291-1295.
6. Ibrahim, E.M., H. Al-Idrissi, A. Al-Farag, D. Al-Tamimi and W. Perry, Situs inversus totalis with
embryonal cell carcinoma of ovaries. Gynecol Oncol, 1984. 18(2): p. 270-273.
7. Al-Idrissi, H.Y., E.M. Ibrahim, A. Abdel Satir, M.B. Satti, S. Al-Kasem and A. Al-Qurain, Primary
hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination
chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C. Hepatogastroenterology,
1985. 32(1): p. 8-10.
8. Ibrahim, E.M., J.T. Anim, H. Al-Idrissi, S. Al Mohaya, J. Al Dossary and C.S. Grant, Abdominal
tuberculosis: a frequent diagnostic challenge. Ann Trop Med Parasitol, 1985. 79(2): p. 163-167.
9. Ahmed, R., B.A. Bopp С, S. Kasattya, H. Al-Idrish, M. Satti, A. Al-Quorain, E. Ibrahim and F. Al-Fiar,
Bibliography of the current world literature. Antimicrob Agents Chemother, 1986. 30: p. 694-
700.
10. AL NAHDI, M., A.M. SULIIMAN, E. IBRAHIM and H. AL IDRISSI, Prevalence of allergic conditions
in an out-patient population in the Eastern Province of Saudi Arabia. Folia allergologica et
immunologica clinica, 1986. 33(6): p. 453-459.
11. Al-Freihi, H., S. Al Mohaya, M. Al Mohsen, E. Ibrahim, M. Al-Sohaibani, K. Twum-Danso and H. Al-
Idrissi, Brucellosis in Saudi Arabia: diverse manifestation of an important cause of pyrexial
illness. Ann Saudi Med, 1986. 6(2): p. 95-100.
12. Al-Freihi, H.M., H.Y. Al-Idrissi, A. Al-Quorain, S.A. Al-Mohaya, A.R. Al-Hamdan and E.M. Ibrahim,
The pattern of colonic diseases in the Eastern Province of Saudi Arabia. J Trop Med Hyg, 1986.
89(1): p. 23-27.
13. Ibrahim, A.W., H. Farag, M. Naguib and E. Ibrahim, Neuroepithelial (colloid) cyst of the third
ventricle in identical twins. Case report. J Neurosurg, 1986. 65(3): p. 401-403.
14. Ibrahim, A.W., M.B. Satti and E.M. Ibrahim, Extraspinal meningioma: case report. Journal of
neurosurgery, 1986. 64(2): p. 328-330.
15. Ibrahim, E., M. Satti, H. Al Idrissi, M. Higazi, G. Magbool and A. Al Quorain, Oral cancer in Saudi
Arabia: the role of alqat and alshammah. Cancer detection and prevention, 1986. 9(3-4): p.
215.
16. Ibrahim, E.M., H.Y. Al-Idrissi, A. Ibrahim, G. Absood, E. Al-Dossary, A. Al-Jammaa, S. Al-Ethan and
A. Eliopoulos, Antiemetic efficacy of high-dose dexamethasone: Randomized, double-blind,

Page | 4
crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy.
European Journal of Cancer and Clinical Oncology, 1986. 22(3): p. 283-288.
17. Ibrahim, E.M., M.B. Satti, H.Y. Al Idrissi, M.M. Higazi, G.M. Magbool and A. Al Quorain, Oral
cancer in Saudi Arabia: the role of alqat and alshammah. Cancer Detect Prev, 1986. 9(3-4): p.
215-218.
18. Ibrahim, E.M., M.B. Satti, H.Y. Al-Idrissi, A. Abdel Satir, S.A. Al-Mohaya, A. Al-Qourain, H. Al-
Freihi and G.H. Abssod, Combination chemotherapy only for stage II non-Hodgkin's lymphoma.
Eur J Cancer Clin Oncol, 1986. 22(2): p. 199-203.
19. Al Nahdi, M., M. Shahed Omer, E. Ibrahim and H. Al-Idrisi, Skin testing in an allergy affected
population of Saudi Arabia. Allerg Immunol (Paris), 1987. 19(4): p. 167-168, 170-161.
20. Al-Freihi, H.M., S.A. Al-Mohaya, E.M. Ibrahim, H.Y. Al-Idrissi and I. Baris, Extrapulmonary
tuberculosis: diverse manifestations and diagnosis challenge. East Afr Med J, 1987. 64(5): p.
295-301.
21. Al-Idrissi, H.Y., M.B. Satti, A. Al-Quorain, E.M. Ibrahim and F.Z. Al-Fiar, Granulomatous
oesophagitis: a case of tuberculosis limited to the oesophagus. Ann Trop Med Parasitol, 1987.
81(2): p. 129-133.
22. Ibrahim, E.M., M.O. Al-Sohaibani, S.A. Al-Suleiman, M.B. Satti, F.A. Al-Mulhim and F. Qaddura,
Tuberculosis of the pancreas: a rare cause of obstructive jaundice and portal hypertension.
Trop Gastroenterol, 1987. 8(3): p. 167-172.
23. Ibrahim EM, A.-I.H., Al-Mohaya S, Larbi EB, Al-Nahdy MS, Al-Hassan AY, Al-Mulhim FA, Al-
Dossary J, Chest roentgenographyin medical emergency. Annals of Saudi Medicine, 1987. 7: p.
57-61.
24. Luqman, W. and E. Ibrahim, The outcome for some methods evaluation of clinical students.
Mater Med Pol, 1987. 19(1): p. 60-61.
25. Taha, S.A., M.B. Satti, N.F. Mitry, H.Y. Al-Idrissi and E.M. Ibrahim, Giant bladder diverticulum: an
unusualpresentation. Br J Urol, 1987. 59(2): p. 189-190.
26. al Quorain, A., M.B. Satti, H.Y. al Idrissi, E.M. Ibrahim, H. al Freihi, A.R. al-Hamdan, J. al Dossary
and M. Abdel Hadi, Digestive system malignancies in the eastern province of Saudi Arabia: an
analysis of 158 patients. Cancer Detect Prev, 1988. 11(3-6): p. 331-336.
27. Al-Idrissi, H., E. Ibrahim, K. Abdullah, W. Ababtain, H. Boukhary and H. Macaulay,
metoclopramide and diphenhydramine. Br. J. Cancer, 1988. 57: p. 308-312.
28. al-Idrissi, H.Y., E.M. Ibrahim, K.A. Abdullah, W.A. Ababtain, H.A. Boukhary and H.M. Macaulay,
Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study
with a combination of dexamethasone, metoclopramide and diphenhydramine. Br J Cancer,
1988. 57(3): p. 308-312.
29. Al-Quorain, A., E.M. Ibrahim, G. Al-Ghassab, F. Al-Mohana and I. Baris, Use of flexible fiberoptic
bronchoscopy in pulmonary diseases--analysis of outcome and prediction of clinically useful
studies. Indian J Chest Dis Allied Sci, 1988. 30(3): p. 167-175.
30. Ibrahim, E.M., M.B. Satti, H.Y. Al-Idrissi, F.A. Al-Mulhim, G.H. Abssod and A. Abdel Jabar, Non-
Hodgkin's lymphoma in Saudi Arabia: prognostic factors and an analysis of the outcome of
combination chemotherapy only, for both localized and advanced disease. Eur J Cancer Clin
Oncol, 1988. 24(3): p. 391-401.
31. Ibrahim EM, A.-F.H., Ryhan TI, Al-Sohaibani MO., Comparative study of students' performance
at a premedical, preclinical, and clinical levels in a medical school. Annals of Saudi Medicine,
1988. 8(6): p. 481-484.
32. Ibrahim EM, S.M., Naguib M, Absood GH, Al-Mulhim FA, Al-Ghassab G. , Hepatocellular
carcinoma in Saudi Arabia: Evaluation of prognostic factors. Annals of Saudi Medicine, 1988.
8(5): p. 329-335.

Page | 5
33. al-Freihi, H.M., A. al-Qurain, Y. al-Gindan, E.M. Ibrahim, M.B. Satti, K. Twum-Danso, H.Y. al-
Idrissi, G. al-Ghassab and A. al-Hamdan, Campylobacter pylori in Saudi patients undergoing
upper gastrointestinal endoscopy: prevalence and effect of conventional therapy.
Hepatogastroenterology, 1989. 36(6): p. 516-518.
34. Al-Nahdi, M.S. and E.M. Ibrahim, The prevalence of allergic disorders in Saudi Arabia:
preliminary analysis based on surveying 300 individuals. Allerg Immunol (Paris), 1989. 21(6): p.
241-242.
35. Ibrahim, A.W., U.M. Chowdhary, A. Ammar and E.M. Ibrahim, The outcome of head injury: the
Saudi experience. Neurol Med Chir (Tokyo), 1989. 29(9): p. 816-819.
36. Ibrahim, E. and H. Al-Idrissi, MECOP-B in the management of non-Hodgkin's Iymphoma:
Preliminary analysis of prognostic factors and total dose-intensity. The Cancer Journal, 1989.
2(12): p. 444-449.
37. IBRAHIM, E., H. AL-IDRISSI, F. AL-MULHIM, A. EL-HASSAN, A. AL-KHATI, J. AL-KHAROUF and R. AL-
KHATIB, The impact of routine chest radiography on the management of febrile neutropenic
adult cancer patients. Cancer journal (Villejuif), 1989. 2(11): p. 395-399.
38. Ibrahim, E.M., A. Uwaydah, F.A. al-Mulhim, A.M. Ibrahim and A.Y. el-Hassan, Tuberculosis in
patients with malignant disease. Indian J Cancer, 1989. 26(2): p. 53-57.
39. Ibrahim EM, A.-I.H., Al-Mulhim FA, El-Hassan AY, Al-Khatti AA, Al-Khatib RI. , The impact of
routine chest radiography on the management of febrile neutropenic adult cancer patients.
The Cancer Journal, 1989. 2(11): p. 395-399.
40. Ibrahim EM, A.-M.S., Al-Idrissi HY, Al-Jasser HH, Al-Fhaid SA, Ibrahim FAS. , Clinical usefulness of
predicted creatinine clearance in cancer patients receiving cisplatin therapy. Annals of Saudi
Medicine, 1989. 9(5): p. 439-442.
41. Sadat-Ali, M. and E.M. Ibrahim, Malignant bone tumours in pregnancy (a report of two cases
and review of literature). Indian J Cancer, 1989. 26(3): p. 151-155.
42. Wahab, A., M. Ibrahim, U.M. Chowdhary, A. Ammar and E.M. Ibrahim, The outcome of head
injuries: the Saudi experience. Nagoya J Med Sci, 1989. 51(1-4): p. 1-6.
43. Al-Gindan YM, A.-Q.A., Ibrahim EM, Al-Freihi H, Al-Mohsen MF, Hussein A, Saied 1, Al-Ghassab
G, Al-Mohana F. , Acute myocardial infarction in the Eastern Province of Saudi Arabia:
retrospective study of 264 patients. Annals of Saudi Medicine, 1990. 10(2): p. 129-136.
44. Al-Sohaibani MO, S.M., Ibrahim EM, Al-Sowayan S. , Histologic patterns of lymphadenopathy in
the Eastern Province of Saudi Arabia. Annals of Saudi Medicine, 1990. 10(5): p. 516-520.
45. El-Hassan AY, A.-M.F., Ibrahim EM, Al-Awami M. Retrospective appraisal of 300 consecutive
mammographic studies, Retrospective appraisal of 300 consecutive mammographic studies.
Annals of Saudi Medicine, 1990. 10(3): p. 285-290.
46. Ibrahim, E.M., Late relapse of Hodgkin's disease after 25 years. Indian J Cancer, 1990. 27(1): p.
17-19.
47. Ibrahim, E.M., Pattern and prognosis of breast cancer at a referral center in Saudi Arabia.
Breast Disease, 1990. 3: p. 187-198.
48. Ibrahim EM, A.-I.H., Al-Khatti AA, Al-Faraj AA, Al-Gindan Y, Al-Khatib RI, Al-Kharouf JA. ,
Piperacillin combined with aminoglycoside for empirical therapy of febrile granulocytopenic
cancer patients. Cancer Therapy and Control, 1990. 1: p. 205-211.
49. Satti, M., K. Twum-Danso, H. Al-Freihi, E. Ibrahim, Y. Al-Gindan, A. Al-Quorain, G. Al-Ghassab, A.
Al-Hamdan and H. Al-Idrissi, Helicobacter pylori-associated uppergastrointestinal disease in
Saudi Arabia: a pathologic evaluation of 298 endoscopic biopsies from 201 consecutive
patients. The American journal of gastroenterology, 1990. 85(5): p. 527.

Page | 6
50. Satti, M.B., H. al-Freihi, E.M. Ibrahim, A. Abu-Melha, G. al-Ghassab, H.Y. al-Idrissi and M.O. al-
Sohaibani, Hepatic granuloma in Saudi Arabia: a clinicopathological study of 59 cases. Am J
Gastroenterol, 1990. 85(6): p. 669-674.
51. Satti, M.B., A.A. Melha, M.O. al-Sohaibani, S. al-Sowayan, A. al-Quorain and E.M. Ibrahim,
Splenic foam cells: a clinico-pathologic analysis of 92 splenectomized patients. Acta Haematol,
1990. 83(1): p. 9-15.
52. Satti, M.B., K. Twum-Danso, H.M. al-Freihi, E.M. Ibrahim, Y. al-Gindan, A. al-Quorain, G. al-
Ghassab, A. al-Hamdan and H.Y. al-Idrissi, Helicobacter pylori-associated upper gastrointestinal
disease in Saudi Arabia: a pathologic evaluation of 298 endoscopic biopsies from 201
consecutive patients. Am J Gastroenterol, 1990. 85(5): p. 527-534.
53. A-IDRISSI, H., E. LARBI, E. IBRAHIM, H. AL-FREIHI, S. AL-MOHAYA, H. AL-JASER and H. SUKKAR, A
RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY OF NIFEDIPINE AND CAPTOPRIL INMILD
AND MODERATELY SEVERE HYPERTENSION IN SAUDIS. Current therapeutic research, 1991.
49(3): p. 340-350.
54. al-Freihi, H.M., A. al-Hamdan, A. al-Qurain, Y.M. al-Gindan, E.M. Ibrahim, G. al-Ghassab and H.I.
Nabi, A single nocturnal dose of famotidine for the treatment of duodenalulcer: evaluation of
efficacy and safety. Trop Gastroenterol, 1991. 12(2): p. 77-82.
55. al-Ghamdi, M.S., E.M. Ibrahim, H.Y. al-Idrissi, A.A. al-Khatti and A. al-Faraj, Antiemetic efficacy of
cimetidine randomized, double-blind, crossover study with dexamethasone in cancer patients
receiving emetogenic chemotherapy. Ann Oncol, 1991. 2(7): p. 517-518.
56. al-Idrissi, H.Y. and E.M. Ibrahim, Hodgkin's disease in adults in Saudi Arabia. Clinical features,
prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only,
for both localized and advanced disease. Int J Cancer, 1991. 47(6): p. 822-826.
57. Al-Idrissi HY, L.E., Ibrahim EM, Al-Freihi HM, Al-Mohaya SA, Al-Jasser H, Sukkar H., A randomized
double-blind cross over study of nifedipine and captopril in mild and moderately severe
hypertension in Saudis. Current Therapeutic Research, 1991. 49(3): p. 340-350.
58. Al-Khadra A, M.F., Ibrahim EM, Patients' knowledge of hypertension and its management.
Journal of Saudi Heart Association, 1991. 3(3): p. 106-109.
59. Al-Sohaibani, M., M.B. Satti, E.M. Ibrahim and S. Al-Sowayan, Reply: Histological patterns of
lymphadenopathy in the eastern province. Ann Saudi Med, 1991. 11(6): p. 716-717.
60. Hegazy, M.M. and E.M. Ibrahim, The pattern and outcome of burn injuries at a burn unit in
Saudi Arabia: Retrospective analysis of consecutive 501 patients. Ann Saudi Med, 1991. 11(3):
p. 255-259.
61. Ibrahim, E., Pattern and prognosis of breast cancer: data from the Eastern Province of Saudi
Arabia. Saudi medical journal, 1991. 12(3): p. 227-231.
62. Ibrahim, E., H. Al-Idrissi, H. Al-Freihi and Y. Al-Gindan, Evaluation of students' performance and
examination procedures in final certifying examinations in internal medicine (1982-1988).
Annals of Saudi medicine, 1991. 11(3): p. 325-330.
63. Ibrahim, E., F. Al-Muhanna, I. Saied, F. Al-Jishi, H. Al-Idrissi, A. Al-Khadra and A. Al-Shehabi,
Public knowledge, misperceptions, and attitudes about cancer in Saudi Arabia. Annals of Saudi
medicine, 1991. 11(5): p. 518-523.
64. Ibrahim, E.M., H.Y. Al-Idrissi, H.M. Al-Freihi and Y.M. Al-Gindan, Evaluation of students'
performance and examination procedures in final certifying examinations in internal medicine
(1982-1988). Ann Saudi Med, 1991. 11(3): p. 325-330.
65. Ibrahim, E.M., H.Y. al-Idrissi, A.H. al-Khadra, N.Y. Kurashi, F.M. al-Jishi, I. Saied, F.A. al-Mohana
and A.F. al-Shehabi, Women's knowledge of and attitude toward breast cancer in a developing
country: implications for program interventions--results based on interviewing 500 women in
Saudi Arabia. J Cancer Educ, 1991. 6(2): p. 73-81.

Page | 7
66. Ibrahim, E.M., F.A. Al-Muhanna, I. Saied, F.M. Al-Jishi, H.Y. Al-Idrissi, A.H. Al-Khadra and A.F. Al-
Shehabi, Public knowledge, misperceptions, and attitudes about cancer in Saudi Arabia. Ann
Saudi Med, 1991. 11(5): p. 518-523.
67. Ibrahim, E.M., M.B. Satti, O.M. Koreich, I.A. Al-Uqali and F.A. Al-Mulhim, Hodgkin's disease
involving the urinary bladder: A case report. Ann Saudi Med, 1991. 11(3): p. 349-351.
68. Ibrahim EM, I.H., Al-Freihi HM, Al-Gindan YM, Evaluation of students performance and
examination procedures in final certifying examinations in internal medicine (1982-l988). .
Annals of Saudi Medicine, 1991. 11(3): p. 325-330.
69. Ibrahim EM, S.M., Koreich OM, Al-Uqali 1, Al-Mulhim FA. , Hodgkin's disease involving the
urinary bladder. Annals of Saudi Medicine, 1991. 11(3): p. 349-351.
70. al-Idrissi, H.Y., E.M. Ibrahim, N.Y. Kurashi and S.A. Sowayan, Breast cancer in a low-risk
population. The influence of age and menstrual status on disease pattern and survival in Saudi
Arabia. Int J Cancer, 1992. 52(1): p. 48-51.
71. Ibrahim, E.M., Alidrissi HY, Al-Khadra A, et al., Ondansetron in the management of emesis in
patients receiving emetogenic chemotherapy. Cancer, Research, Therapy and Control, 1992. 3:
p. 1-6.
72. Kurashi, N.Y., A. al-Hamdan, E.M. Ibrahim, H.Y. al-Idrissi and T.H. al-Bayari, Community acquired
acute bacterial and atypical pneumonia in Saudi Arabia. Thorax, 1992. 47(2): p. 115-118.
73. Al-Idrissi, H., E. Ibrahim, F. Hassan and A. Al-Nabhan, A randomised, double-blind, crossover
study of cilazapril and captopril in mild to moderately severe hypertension in Saudis. JOURNAL
OF DRUG DEVELOPMENT, 1993. 5: p. 215-215.
74. al-Idrissi, H.Y. and E.M. Ibrahim, Hodgkin's disease in adults in Saudi Arabia. Clinical features,
prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only,
for both localized and advanced disease. Int J Cancer, 1993. 47(6): p. 822-826.
75. al-Idrissi, H.Y., E.M. Ibrahim, F. Hassan, A.A. al-Nabhan, A.H. al-Khadra and F.A. Muhanna, A
randomized, double-blind, crossover study of cilazapril and captopril in mild to moderately
severe hypertension in Saudis. Journal of Drug Development, 1993. 5(4): p. 215-223.
76. Al-Muhanna, F., G. Ghassab, I. Al-Rahman, A. Al-Qurain, E. Ibrahim, K. Malhotra and S. Al-
Mohaya, Acute renal failure as seen in a hemolysis unit. Saudi Med Journal, 1993. 14(5): p. 432-
435.
77. Al-Mulhim FA, Ibrahim EM, Sowayan SA and W. L, An impact of decision analysis on the
management of advanced hepatocellular carcinoma. Cancer Research, Therapy and Control,
1993. 3(273-281).
78. Sadat-Ali, M., A.Y. El-Hassan, E.M. Ibrahim, H. Al-Frehi and F. Al-Muhanna, Postmenopausal
osteoporosis in Saudi women: A pilot screening. Ann Saudi Med, 1993. 13(3): p. 272-274.
79. Al-Bar, A., E. Ibrahim, T. Tamimi, S. Assuhaimi and A. Ibrahim, Hodgkin’s and non-Hodgkin’s
lymphoma: Analysis of population-based data from the Eastern Province of Saudi Arabia.
Saudi Med J, 1994. 15(4): p. 290-294.
80. Al-Khadra, A., G. Ladipo, A. Hussain, E. Ibrahim and Y. Al-Gindan, In-hospitalmortality of acute
myocardial infarction in Saudi Arabia. Journal of the Saudi Heart Association, 1994. 6(2): p. 123-
127.
81. Al-Mulhim, F.A. and E.M. Ibrahim, Magnetic resonance imaging of the spine: An initial
experience. Ann Saudi Med, 1994. 14(4): p. 333-337.
82. Al-Quorain, A., A. Ammar, M. Al-Awami, M. Hegazi, E.-M. HA, E. Ibrahim, Y. Al-Muezen, F.
Nassim, Y. Al-Gindan and H. Al-Freihi, Comparison of intravenous famotidine and rantidine in
suppressing gastric acid secretion in critically ill patients. Current Therapeutic Research 1994.
55(10): p. 1263-1270.

Page | 8
83. al-Quorain, A., M.B. Satti, A.R. al-Hamdan, Y. al-Gindan, E. Ibrahim, R. Khatib and H. al-Freihi,
Pattern of chronic liver disease in the eastern province of Saudi Arabia. A hospital-based
clinicopathological study. Trop Geogr Med, 1994. 46(6): p. 358-360.
84. Al-Mulhim, F. and E. Ibrahim, Evaluation of students’ performance in diagnostic radiology.
Journal of the Bahrain Medical Society 1995. 17(1): p. 30-34.
85. Al-Mulhim, F.A., E.M. Ibrahim, A.Y. El-Hassan and H.M. Moharram, Magnetic resonance
imaging of tuberculous spondylitis. Spine, 1995. 20(21): p. 2287-2292.
86. Al-Sultan, A. and E. Ibrahim, Factors influencing medical student’s career preferences. Journal
of the Bahrain Medical Society, 1995. 7(1): p. 7-12.
87. Ibrahim, E.M., Information superhighway…….. Are we in the fast lane? Journal of family &
community medicine, 1995. 2(1): p. 9.
88. Al Quorain, A., E. Ibrahim and A. Al Sultan, Diagnostic and therapeutic value of ERCP and
prediction of outcome: A retrospective analysis. Saudi Journal of Gastroenterology, 1996. 2(3):
p. 138.
89. Al Tamimi, T., A. Al-Bar, S. Al-Suhaimi, E. Ibrahim, A. Ibrahim, L. Wosornu and G. Gabriel, Lung
cancer in the Eastern region of Saudi Arabia: A population-based study. Annals of Saudi
medicine, 1996. 16(1): p. 3.
90. Al Tamimi, T.M., A. Al-Bar, S. Al-Suhaimi, E. Ibrahim, A. Ibrahim, L. Wosornu and G.S. Gabriel,
Lung cancer in the Eastern region of Saudi Arabia: A population-based study. Ann Saudi Med,
1996. 16(1): p. 3-11.
91. Al-Bar, A., E. Ibrahim, T. Al-Tamimi, S. Assuhaimi, A. Ibrahim, G. Gabriel and A. Mishriky,
Leukemia in the eastern region of Saudi Arabia: A population-based study(1987-1988). Annals
of Saudi medicine, 1996. 16(5): p. 521-526.
92. Ibrahim, E., F. Nassim and R. Ibrahim, Simulation model for predicting survival in women
receiving adjuvant therapy for early breast cancer. The Cancer Journal from Scientific
American, 1996. 2(4): p. 234-240.
93. Ibrahim, E., F. Nassim and R. Ibrahm, Simulations model for predicting survival in women
receiving adjuvant therapy for early breast cancer. The cancer journal from Scientific American,
1996. 2(4): p. 234.
94. Ibrahim, E.M., R.F. Bunyan, F.A. al-Mulhim, A.A. al-Nabhan and R.E. Ibrahim, Chemotherapy
with MECOP-B for intermediate-grade and high-grade non-Hodgkin's lymphoma in Saudi
Arabia: clinical results and analysis of prognostic factors. Acta Haematol, 1996. 96(3): p. 126-
134.
95. Mohammed, E., M. Nur, N. Kurashi, E. Ibrahim and K. Ammar, Survival after stroke in Saudis: a
hospital based study. The Journal of Family and Community Medicine 1996. 3(1): p. 48-52.
96. Mohammed, E.G.E., M.A. Nur, N.Y. Kurashi, E. Ibrahim and K. Ammar, Survival after stroke in
Saudis: A hospital based study. Journal of family & community medicine, 1996. 3(1): p. 48.
97. Al Tamimi, T.M., E.M. Ibrahim, A.-W.M. Ibrahim, A.A. Al-Bar, S.A. Assuhaimi, G.S. Gabriel, A.M.
Mishriky, H.Y. Al-Idrissi, M.O. Al-Sohaibani and M.H. Al-Sibai, Cancer in the eastern region of
Saudi Arabia: a population-based study (1987-1988). Annals of Saudi medicine, 1997. 17: p. 53-
65.
98. Al-Bar, A., T. Al-Tamimi, E. Ibrahim and A. Ibrahim, Establishing a computerized tumor registry:
the Eastern Province experience. Saudi Medical Journal, 1997. 18(5): p. 488-491.
99. Al-Tamimi, T., A. Ibrahim, A. Mishriky, G. Gabriel, E. Ibrahim, A. Al-Bar and S. Assuhaimi, Thyroid
cancer in the Eastern Region of Saudi Arabia: a population-based study(1987-1988). Saudi
Medical Journal 1997. 18(4): p. 374-380.

Page | 9
100. Al-Tamimi, T., A.-W. Ibrahim, A. Mishriky, G. Gabriel, E. Ibrahim, A. Al-Bar and S. Assuhaimi,
Thyroid cancer in the Eastern Region of Saudi Arabia: A population-based study (1987-1988).
Saudi medical journal, 1997. 18(4): p. 374-380.
101. Ibrahim, E.M. and F.A. Al-Mulhim, Effect of granulocyte-macrophage colony-stimulating factor
on chemotherapy-induced oral mucositis in non-neutro-peniccancer patients. Medical
Oncology, 1997. 14(1): p. 47-51.
102. Al-Mulhim, F., E. Ibrahim, A. Al-Nabhan, R. Ibrahim, F. Nassim and G. Ladipo, Clinical prediction
rule for pulmonary infiltrates. Saudi medical journal, 1998. 19(3): p. 306-312.
103. Ibrahim, E. and F. Al-Mulhim, The effect of GM-CSF in chemotherapy-induced oral mucositis in
non-neutropeniccancer patients. Biotherapy in Cancer, 1998. 2(3): p. 71-73.
104. Ibrahim, E., F. Al-Mulhim, F. Al-Muhanna and A. Al-Amri, The effect of GM-CSF in
chemotherapy-induced oral mucositis in non-neutropeniccancer patients. Journal of Family
and Community Medical, 1998. 5, 37-43(2): p. 37-43.
105. Ibrahim, E.M., F.A. Al-Mulhim, A. Al-Amri, F.A. Al-Muhanna, A.A. Ezzat, R.K. Stuart and D. Ajarim,
Breast cancer in the eastern province of Saudi Arabia. Medical oncology, 1998. 15(4): p. 241-
247.
106. Ibrahim, E.M., F.A. Al-Mulhim, F.A. Al-Muhanna and A. Al-Amri, Effect of granulocyte-
macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-
neutropenic cancer patients. Journal of family & community medicine, 1998. 5(1): p. 37.
107. Ezzat, A.A., E.M. Ibrahim, M.A. Raja, S. Al-Sobhi, A. Rostom and R.K. Stuart, Locally advanced
breast cancer in Saudi Arabia: high frequency of stage III in a young population. Medical
oncology, 1999. 16(2): p. 95-103.
108. Ibrahim, E., A. Ezzat, M. Raja, M. Rahal, D. Ajarim, B. Mann, A. Baloush, R. Stuart and S.
Bazarbashi, Primary gastric non-Hodgkin's lymphoma: clinical features, management, and
prognosis of 185 patients with diffuse large B-cell lymphoma. Annals of oncology, 1999. 10(12):
p. 1441-1449.
109. Ibrahim, E.M. and R.K. Stuart, Evidence-based medicine for the new millennium: Critical
appraisal and pragmatic approach. Annals of Saudi medicine, 1999. 19(4): p. 295-296.
110. Rahal, M., S. Bazarbashi, A. El-Weshi, M. Raja, C. Pai, M. El-Foudeh, A. Al-Sayed, A. Ezzat, D.
Ajarim and E. Ibrahim, Salvage chemotherapy for hodgkin's disease - a seven-drug containing
regimen with and without stem cell transplant. Eur J Cancer, 1999. 35: p. 1337.
111. Al-Qurashi, F., M. Ayas, F. Al-Sharif, E. Sahovic, H. El-Solh, F. Al-Mohareb, N. Chuadhri, H. Al-
Omar, M. Sarhan and R. Stuart. Outcome of second allogeneic bone marrow transplantation
after myeloablative conditioning and its correlation with prognostic factors. in BLOOD. 2000.
AMER SOC HEMATOLOGY 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA.
112. Bazarbashi, S., M.A. Raja, A. El Sayed, A. Ezzat, E. Ibrahim, S. Kattan, A. Kardar, A. Peracha, E.
Lindstedt and K. Hanash, Prospective phase II trial of alternating intravesical Bacillus Calmette-
Guerin (BCG) and interferon alpha IIB in the treatment and prevention of superficial
transitional cell carcinoma of the urinary bladder: preliminary results. J Surg Oncol, 2000.
74(3): p. 181-184.
113. Ezzat, A., E. Ibrahim, R. Stuart, D. Ajarim, S. Bazarbashi, M. El-Foudeh, M. Rahal, A. Al-Sayed and
J. Berry, Adding high-dose tamoxifen to CHOP does not influence response or survival in
aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial.
Medical Oncology, 2000. 17(1): p. 39-46.
114. Ezzat, A.A., E.M. Ibrahim, D.S. Ajarim, M.M. Rahal, M.A. Raja, R.K. Stuart, A.M. Tulbah, A. Kandil,
O.A. Al-Malik and S.M. Bazarbashi, High complete pathological response in locally advanced
breast cancer using paclitaxel and cisplatin. Breast cancer research and treatment, 2000. 62(3):
p. 237-244.

Page | 10
115. Ibrahim, E., A. Ezzat, A. Baloush, Z. Hussain and G. Mohammed, Pregnancy-associated breast
cancer: a case—control study in a young population with a high-fertility rate. Medical
Oncology, 2000. 17(4): p. 293-300.
116. Rahal, M., A. Ezzat, E. Ibrahim, D. Ajarim, A. Raja, R. Stuart, A. Tulbah, A. Kandi and S. Bazarbashi,
Neoadjuvant High-Dose Sequential Chemotherapy with Adriamycin, Paclitaxel, and
Cyclophosphamide Is Feasible and Effective in PoorPrognostic Patients with Locally Advanced
Breast Cancer. BREAST CANCER RESEARCH AND TREATMENT, 2000. 64(1): p. 261-261.
117. Rahal, M.M., A.A. Ezzat, E.M. Ibrahim, D.S. Ajarim, A. Raja, R.K. Stuart, A.M. Tulbah, A. Kandil
and S.N. Bazarbashi, Neoadjuvant high-dose sequential chemotherapy with adriamycin (a),
paclitaxel (p), and cyclophosphamide (c) is feasible and effective in poor prognostic patients
with locally advanced breast cancer (labc). . Breast Cancer Research and Treatment 2000. 64: p.
71.
118. El-Weshi, A., Y. Khafaga, A. Allam, V. Mosseri, E. Ibrahim, M. El-Serafi and S. El-Badawi,
Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation
in stage III and IV nasopharyngealcarcinoma-a phase II study. Acta Oncologica, 2001. 40(5): p.
574-581.
119. Ezzat, A. and E. Ibrahim, High-dose chemotherapy and autologus bone marrow transplantation
have no benefit over standard chemotherapy for aggressive non-Hodgkin’s lymphoma.
Evidence-Based Oncology, 2001. 2: p. 98-100.
120. Ezzat, A.A., E.M. Ibrahim, A.N. El Weshi, Y.M. Khafaga, M. AlJurf, J.M. Martin, D.S. Ajarim, S.N.
Bazarbashi, R.K. Stuart and E. Zucca, Localized non‐Hodgkin's lymphoma of Waldeyer's ring:
Clinical features, management, and prognosis of 130 adult patients. Head & neck, 2001. 23(7):
p. 547-558.
121. Ibrahim, E., A. Ezzat, A. El-Weshi, J. Martin, Y. Khafaga, W. Al Rabih, D. Ajarim, M. Al-Foudeh and
E. Zucca, Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features,
management, and prognosis of 66 patients. Annals of oncology, 2001. 12(1): p. 53-58.
122. Alrajhi, A.A., E.A. Ibrahim, E.B. De Vol, M. Khairat, R.M. Faris and J.H. Maguire, Fluconazole for
the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med, 2002.
346(12): p. 891-895.
123. Baslaim, M.M., O.A. Al Malik, S.S. Al-Sobhi, E. Ibrahim, A. Ezzat, D. Ajarim, A. Tulbah, M.A.
Chaudhary and R.A. Sorbris, Decreased axillary lymph node retrieval in patients after
neoadjuvant chemotherapy. The American journal of surgery, 2002. 184(4): p. 299-301.
124. Ibrahim, E.M., R. Al-Saad and A.L. Wishi, Patient Education-Appraisal of Communication Skills
and Patients' Satisfaction in Cross-language Encounters in Oncology Practice. IEEE Transactions
on Energy Conversion, 2002. 17(4): p. 216-221.
125. Ibrahim, E.M., R. Al‐Saad, A.L. Wishi, Y.M. Khafaga, G.E. Hussainy, A. Nabhan, A.A. Ezzat, D.S.
Ajarim, S. Bazarbashi and A. Radwi, Appraisal of communication skills and patients’ satisfaction
in cross‐language encounters in oncology practice. Journal of Cancer Education, 2002. 17(4): p.
216-221.
126. Tulbah, A.M., E.M. Ibrahim, A.A. Ezzat, D.S. Ajarim, M.M. Rahal, A.N. El Weshi and R. Sorbris,
HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or
prognosticate survival in patients with locally advanced breast cancer. Medical Oncology,
2002. 19(1): p. 15-23.
127. Al-Jurf, M., T. Quaideh, A. Ezzat, E. Ibrahim and A. Tabkhi, Antigen and/or immune-driven
immunoproliferative disorders. Annals of Oncology 2003. 14: p. 1595-1606.
128. Ezzat, A., M. Rahal, D. Ajarim, E. Ibrahim, S. Bazarbashi, M. Raja, A. El Weshi and M. El Foudeh,
Dose-dense neoadjuvant sequential chemotherapy in the management of locally advanced
breast cancer: A phase II study. Proc Am Soc Clin Oncol, 2003. 22: p. 51.

Page | 11
129. Al Shanqeeti, A., P. Seth, M. Aslam, H. El Solh, M. Aljurf, F. Al-Qurashi, M. Ayas, F. Al Sharif, E.
Ibrahim and E. Sahovic, Second allogeneic bone marrow transplantation after myeloablative
conditioning analysis of 43 cases from single institution. Hematology, 2004. 9(2): p. 123-129.
130. Ezzat, A., E. Ibrahim, D. Ajarim, M. Rahal, M. Raja, A. Tulbah, O. Al-Malik, M. Al-Shabanah and R.
Sorbris, Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally
advanced breast cancer: analysis of 126 patients. Br J Cancer, 2004. 90(5): p. 968-974.
131. Ibrahim, E. and A. Ezzat, Failure of the International Prognostic Index to prognosticate outcome
in primary gastric DLBC lymphoma. Annals of oncology, 2004. 15(5): p. 841-841.
132. Ibrahim, E., E. Fawzy, J. Al-Maghraby, H. Kanaan, A. Radwi and Y. Bahadur, Her-2/neu receptor
status and non-small cell lung cancer: is there any prognostic correlation? Kasr-el-Aini Journal
of Clinical Oncology and Nuclear Medicine 2005. 1(2).
133. Ibrahim, E.M., A.A. Ezzat, M.M. Rahal, M.M. Raja and D.S. Ajarim, Adjuvant chemotherapy in
780 patients with early breast cancer: 10-year data from Saudi Arabia. Med Oncol, 2005.
22(4): p. 343-352.
134. Elhadd, T., A. AlAmoudi, S. AlGhamdi, E. Ibrahim and H. Elshiekh, The safety and efficacy of
chinese herbal medicine PHS-e2 (Glucoherb) in streptozotocin–induced diabetic wistar rats.
Endocrine Abstracts, 2006. 11: p. P276.
135. Ibrahim, E. and M. Boulos, Access to online information by adult Saudi cancer patients. Journal
of Health Conusumers of the Internet 2006. 10(4).
136. Ibrahim, E.M. and M.N.K. Boulos, Access to online information by adult Saudi cancer patients.
Journal of Consumer Health on the Internet, 2006. 10(4): p. 33-43.
137. Ibrahim, E.M., R.L. Stewart, K. Corke, A.D. Blackett, J.A. Tidy and M. Wells, Upregulation of CD44
expression by interleukins 1, 4, and 13, transforming growth factor-beta1, estrogen, and
progestogen in human cervical adenocarcinoma cell lines. Int J Gynecol Cancer, 2006. 16(4): p.
1631-1642.
138. Ibrahim, E.M., A.A. Zeeneldin, A.M. Al-Gahmi, Y.A. Sallam, E.E. Fawzi and Y.A. Bahadur, Safety
and efficacy of cetuximab-chemotherapy combination in Saudi patients with metastatic
colorectal cancer. Indian journal of cancer, 2007. 44(2): p. 56.
139. Hegazi, M., R. Kumar, Z. Bitar and E. Ibrahim, Pancytopenia related to Graves' disease. Annals of
Saudi medicine, 2008. 28(1): p. 48.
140. Ibrahim, E., S. Bin, L. Banjar, S. Awadalla and M. Abomelha, Current and future cancer burden in
Saudi Arabia: meeting the challenge. Hematology/oncology and stem cell therapy, 2008. 1(4):
p. 210.
141. Ibrahim, E.M., A.A. Zeeneldin, T.R. El-Khodary, A.M. Al-Gahmi and B.M.B. Sadiq, Past, present
and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi journal of
gastroenterology: official journal of the Saudi Gastroenterology Association, 2008. 14(4): p. 178.
142. Ibrahim, E.M., A.A. Zeeneldin, B.B. Sadiq and A.A. Ezzat, The present and the future of breast
cancer burden in the Kingdom of Saudi Arabia. Medical Oncology, 2008. 25(4): p. 387-393.
143. Ibrahim, E., A. Al-Gahmi, J. Zekri, S. Awadalla, T. Elkhodary, E. Fawzy, Y. Bahadur, M. Elsayed, A.
Zeeneldin, R. Al-Ahmadi, and A. Linjawi, Preoperative Systemic Therapy in Locally Advanced
Breast Cancer: A Single Institution Experience. Ecancermedicalscience, 2009. 3 p. Article
Number: 161 DOI.
144. Ibrahim, E., A.M. Al-Gahmi, A.A. Zeenelin, J.M. Zekri, T.R. Elkhodary, H.E. Gaballa, E.E. Fawzy and
M.S. Alzahrani, Basal vs. luminal A breast cancer subtypes: a matched case-control study using
estrogen receptor, progesterone receptor, and HER-2 as surrogate markers. Medical Oncology,
2009. 26(3): p. 372-378.
145. Ibrahim, E., A.M. Al-Gahmi, A.A. Zeenelin, J.M. Zekri, T.R. Elkhodary, H.E. Gaballa, E.E. Fawzy,
M.E. El sayed and M.S. Alzahrani, Basal vs. luminal A breast cancer subtypes: a matched case-

Page | 12
control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate
markers. Med Oncol, 2009. 26(3): p. 372-378.
146. Ibrahim, E., R. Bunyan, F. Al-Mulhim, A. Al-Nabhan and R. Ibrahimá, Chemotherapy with
MECOP-B for intermediate-grade and high-grade non-Hodgkin’s lymphoma in Saudi Arabia:
clinical results and analysis of prognostic factors. Acta haematologica, 2009. 96(3): p. 126-134.
147. Ibrahim, E.M., A. Al-Gahmi, J. Zekri, S. Awadalla, T. Elkhodary, E. Fawzy, Y. Bahadur, M. Elsayed,
A. Zeeneldin and R. Al-Ahmadi, Pre-operative systemic therapy in locally advanced breast
cancer: a single institution experience. ecancermedicalscience, 2009. 3.
148. Satti, M., M. Al-Sohaibani, S. Al-Sowayan, A. Al-Quorain and E. Ibrahim, Splenic foam cells: a
clinico-pathologic analysis of 92 splenectomized patients. Acta haematologica, 2009. 83(1): p.
9-15.
149. Boulos, D.N., R.R. Ghali, E.M. Ibrahim, M.N. Boulos and P. Abdelmalik, An eight-year snapshot of
geospatial cancer research (2002-2009): clinico-epidemiological and methodological findings
and trends. Med Oncol, 2010.
150. Ibrahim, E., J. Zekri and H. Abdelrahman, Adjuvant Platinum-Based Chemotherapy versus
Observation in Non-Small Cell Lung Cancer: Meta-analysis of Trials with Intermediate- and
Long-Term Follow-up. The Open Lung Cancer Journal, 2010. Accepted for Publication.
151. Ibrahim, E., J. Zekri and B. Bin Sadiq, Cetuximab-Based Therapy for Metastatic Colorectal
Cancer: A Metaanalysis of the Effect of K-ras Mutations. Inter J Colorectal Disease, 2010.
Accepted for Publication.
152. Ibrahim, E.M., Frontline gefitinib in advanced non-small cell lung cancer: Meta-analysis of
published randomized trials. Annals of thoracic medicine, 2010. 5(3): p. 153.
153. Ibrahim, E.M., T.R. Elkhodary, J.M. Zekri, Y. Bahadur, M.E. EL‐SAYED, A.M. AL‐GAHMI, S.A.J. Rizvi,
A.H. Hassouna, E.E. Fawzy and S.S. Awadalla, Prognostic value of lymph node ratio in poor
prognosis node‐positive breast cancer patients in Saudi Arabia. Asia‐Pacific Journal of Clinical
Oncology, 2010. 6(2): p. 130-137.
154. Ibrahim, E.M. and J.M. Zekri, Folic acid supplementation for the prevention of recurrence of
colorectal adenomas: metaanalysis of interventional trials. Medical Oncology, 2010. 27(3): p.
915-918.
155. Ibrahim, E.M., J.M. Zekri and B.M.B. Sadiq, Cetuximab-based therapy for metastatic colorectal
cancer: a meta-analysis of the effect of K-ras mutations. Int J Colorectal Dis, 2010. 25(6): p.
713-721.
156. Zekri, J., E. Ibrahim, B.B. Sadiq, A. Al-Gahmi, A. Zeeneldin, T. Elkhodary, H. Gaballa, E. Fawzy, M.
Elsayed and Y. Bahadur, A matched group study of triple negative versus HER-2 positive
(irrespective of hormonal status) breast cancer: two subtypes with high-risk features and poor
outcome. ecancermedicalscience, 2010. 4.
157. Zekri, J.M., E. Ibrahim, A. Al-Gahmi, A. Zeeneldin, T. Elkhodary, H. Gaballa, E. Fawzy, M. Elsayed,
Y. Bahadur and S. Awadalla, A matched case-control study of Triple negative vs. HER-2 positive
(irrespective of hormonal status) breast cancer: two subtypes with high risk features and poor
outcome. The Gulf journal of oncology, 2010(7): p. 14-20.
158. Zekri, J.M., E. Ibrahim, B.B. Sadiq, A.M. Al-Gahmi, A.A. Zeeneldin, T.R. Elkhodary, H.E. Gaballa,
E.E. Fawzy, M.E. Elsayed and Y. Bahadur, A Matched Group Study of Triple Negative vs. HER-2
Positive (irrespective of hormonal status) Breast Cancer: Two Subtypes with High Risk Features
and Poor Outcome. Surgery, 2010. 30(75): p. 1.0.
159. Boulos, D.N.K., R.R. Ghali, E.M. Ibrahim, M.N.K. Boulos and P. AbdelMalik, An eight-year
snapshot of geospatial cancer research (2002–2009): clinico-epidemiological and
methodological findings and trends. Medical Oncology, 2011. 28(4): p. 1145-1162.

Page | 13
160. Ibrahim, E.M. and K.M. Abouelkhair, Clinical outcome of panitumumab for metastatic
colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials.
Medical Oncology, 2011. 28(1): p. 310-317.
161. Ibrahim, E.M., K.M. Abouelkhair, O.A. Al-Masri, N.C. Chaudry and G.A. Kazkaz, Cetuximab-based
therapy is effective in chemotherapy-naive patients with advanced and metastatic non-small-
cell lung cancer: a meta-analysis of randomized controlled trials. Lung, 2011. 189(3): p. 193-
198.
162. Ibrahim, E.M. and A. Al-Homaidh, Physical activity and survival after breast cancer diagnosis:
meta-analysis of published studies. Medical oncology, 2011. 28(3): p. 753-765.
163. Ibrahim, E.M.A.I.M., Systematic Review: Anti–Epidermal Growth Factor Receptor Treatment
Effect Modification by KRAS Mutations in Advanced Colorectal Cancer. Ann Intern Med 2011.
154: p. 37-49.
164. Elsheikh, H., E. Ibrahim, S. Al-Ghamdi, T. Elhadd and T. Al-Malki, Metabolic efficacy of PHS-E 2
(Glucoherb), a chinese antidiabetic herbal health product, in Streptozotocin-induced diabetic
wistar rats. Saudi Journal for Health Sciences, 2012. 1(1): p. 9.
165. Ibrahim, E.M., K.M. Abouelkhair, G.A. Kazkaz, O.A. Elmasri and M. Al-Foheidi, Risk of second
breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis. BMC cancer, 2012.
12(1): p. 197.
166. Ibrahim, E.M., T.M. Al-Fayea and G.A. Kazkaz, The clinical role of cetuximab in the management
of non-small-cell lung cancer. Lung Cancer Management, 2012. 1(1): p. 3-5.
167. Ibrahim, E.M., G.A. Kazkaz, K.M. Abouelkhair, A.M. Bayer and O.A. Elmasri, Sunitinib adverse
events in metastatic renal cell carcinoma: a meta-analysis. International Journal of Clinical
Oncology, 2012: p. 1-10.
168. Al-Foheidi, M., M.M. Al-Mansour and E.M. Ibrahim, Breast cancer screening: review of benefits
and harms, and recommendations for developing and low-income countries. Medical
Oncology, 2013. 30(2): p. 1-15.
169. Ibrahim, E., M. Al-Mansour, M. Al-Foheidi and G. Kazkaz, Interim FDG-PET in Diffuse Large B-Cell
Non-Hodgkin’s Lymphoma: A Meta-Analysis. World Journal of Medical Research, 2013. 2(4): p.
25-45.
170. Ibrahim, E.M., M. Al-Foheidi, M.M. Al-Mansour and G.A. Kazkaz, Clinical utility of cetuximab-
induced skin toxicity: The jury is still out. Journal of Symptoms and Signs, 2013. 2(5): p. 315.
171. Ibrahim, E.M., G.A. Kazkaz, K.M. Abouelkhair, M.M. Al-Mansour, T.M. Al-Fayea, M. Al-Foheidi,
A.M. Bayer and O.A. Elmasri, Increased risk of second lung cancer in hodgkin’s lymphoma
survivors: a meta-analysis. Lung, 2013. 191(1): p. 117-134.
172. Scartozzi, M., R. Giampieri, A. Mandolesi, K. Abouelkhair, C. Loretelli, M. Del Prete, L. Faloppi, M.
Bianconi, E. Ibrahim and S. Cascinu. Molecular biomarkers for a prognostic stratification of K-RAS
wild type colorectal cancer patients receiving irinotecan-cetuximab: Preliminary results of a
prospective study. in EUROPEAN JOURNAL OF CANCER. 2013. ELSEVIER SCI LTD THE BOULEVARD,
LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND.
173. Scartozzi, M., R. Giampieri, A. Mandolesi, K.M. Abouelkhair, C. Loretelli, M. Del Prete, L. Faloppi,
A. Bittoni, M. Bianconi and L. Cecchini. Prognostic stratification of k-RAS wild type colorectal
cancer patients receiving irinotecan-cetuximab treatment: Preliminary results of a prospective
study. in JOURNAL OF CLINICAL ONCOLOGY. 2013. AMER SOC CLINICAL ONCOLOGY 2318 MILL
ROAD, STE 800, ALEXANDRIA, VA 22314 USA.
174. RAGAZ, J., E. IBRAHIM, M. LEAHY and A. WILLAN. SOME OBSERVATIONS ON THE HORMONAL-
THERAPY OF METASTATIC BREAST-CANCER (MBC)-AMINOGLUTETHIMIDE (AG) WITH OR
WITHOUT TAMOXIFEN (T). in PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER

Page | 14
RESEARCH. 1981. AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR,
PHILADELPHIA, PA 19106-4404 USA.
175. Ragaz, J., E. Ibrahim, M. LEAHY and A. Willan. A COMBINATION OF HORMONES FOR METASTATIC
BREAST-CANCER (MBC)-AMINOGLUTETHIMIDE+ TAMOXIFEN (AG+ T), VS AG ALONE, VS T
ALONE. in PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. 1981. AMER
ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA.
176. Ragaz, J., M. Leahy, E. Ibrahim, J. Spinelli and A. Willan. MEDICAL ADRENALECTOMY WITH
AMINOGLUTETHIMIDE (AG) AND TAMOXIFEN (T) FOR METASTATIC BREAST-CANCER (MBC)-
EFFECT ON RESPONSE (R) AND PITUITARY-HORMONES. in PROCEEDINGS OF THE AMERICAN
ASSOCIATION FOR CANCER RESEARCH. 1982. AMER ASSOC CANCER RESEARCH PUBLIC LEDGER
BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W., PHILADELPHIA, PA 19106.
177. RAGAZ, J., E. IBRAHIM, M. LEAHY, H. SILVER and J. SPINELLI. AMINOGLUTETHEMIDE (AG) VS AG
AND TAMOXIFEN (T) IN THE THERAPY OF METASTATIC BREAST-CANCER (MBC). in PROCEEDINGS
OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. 1983. AMER ASSOC CANCER
RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA.
178. Ibrahim, E.M., M. Al-Foheidi, M.M. Al-Mansour, G.A. Kazkaz and T.E. Yunus, The prognostic and
predicting roles of tumor-Infiltrating lymphocytes in breast cancer: A meta-analysis. The Open
Breast Cancer J, 2014. 6(3): p. 9-19.
179. Ibrahim, E.M., M.E. Al-Foheidi, M.M. Al-Mansour and G.A. Kazkaz, The prognostic value of
tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis. Breast Cancer
Res Treat, 2014. 148(3): p. 467-476.
180. Khayyat, Y.M. and E.M. Ibrahim, Public awareness of colon cancer screening among the general
population: A study from the Western Region of Saudi Arabia. Qatar Med J, 2014. 2014(1): p.
17-24.

Page | 15
EDITED BOOKS & CHAPTERS IN BOOKS
1. El-Mawla NG, Ibrahim EM, El-Serafy M. The use of systemic chemotherapy in the management
of advanced breast cancer. In: Breast Cancer: A Comprehensive Approach (1st Edition), Eds.
Omer S, Contesso G, 161-l69, 1984. The book was published by the Cairo Medical Syndicate
Scientific Committee and supported by the Egyptian Ministry of Health and the Egyptian
Academy of Scientific Research and Technology. The book was written by several experts in
breast cancer disease: pathologists, surgeons, medical oncologists, radiotherapists, and
epidemiologists from Saudi Arabia, Egypt, France (Gustave-Roussy Institute), USA (The American
Cancer Society). It addresses various aspects of breast cancer.
2. Ibrahim EM, El-Serafy M. Chemotherapy in the management of metastatic breast cancer. In:
Breast Cancer (2nd Edition), Eds. Omer S, Contesso G, 126-131, 1987. The book was published
by Korba, London. The book was written with contribution from authors from Egypt, France,
USA and Saudi Arabia to provide an updated experience of all controversial issues in the
diagnosis and management of breast cancer.
3. Ibrahim EM. The editor of book titled "Comprehensive Approach to Clinical Examination". It
contained 15 chapters in 535 pages. The book is designed in a way that should make
understanding, learning and studying easier. In preparing it, many standard textbooks and
monographs have been reviewed. The book contained many illustrations of key examination
techniques, graphs, and easily understood tables of important facts; its style was intended to
capture the reader's interest and imagination. Though several chapters were written by
different contributors, a unified format is maintained throughout. I believe that this book was
able to satisfy the need for a clear guide to clinical medicine, and it has certainly competed
favorably with similar books in this respect, nevertheless, it was never predestined to serve as
an extensive textbook in theoretical medicine. Although a chapter was devoted to common
symptoms, the cardinal symptoms of organ systems were reinforced under the appropriate
chapters. Some of the commoner and more important diseases have been covered in a
simplified way. Moreover, a chapter that introduces the readers to the basis of radiological
investigations; and another dedicated to illustrate the basic principles of electrocardiography,
were included. The two chapters are added to ensure a quick basic understanding of these
important investigations. A third chapter was also added to promote the philosophy of medical
informatics. Neither, pediatric nor gynecological examination were discussed.
4. Ibrahim EM. The editor of a new book “Comprehensive Approach to Case Studies in Medicine”.
The book addressed a novel approach to problem-oriented clinical medicine. It contained 40
chapters with contributions from several faculty staff at King Faisal University and consultants at
King Faisal Specialist Hospital. The book came in 239 pages.

Page | 16
5. Ibrahim EM, El-Serafy M. Chemotherapy in the management of metastatic breast cancer. In:
Breast Cancer (3rd edition), Eds. Omer S, Contesso G, 137-142, 1997. The book was published
by the Association Medicale Franco Egyptienne.
6. Ibrahim EM, Asma Tulbah. Basic Principles of Tumor Pathology and Biology. In: Basic Principles
of Nuclear Medicine (First edition), Eds. Abdelhamid El-Gazzar, Springer-Verlarg, New York,
2001, p 169-178.
7. El-Gazzar, Ibrahim EM. Nuclear Medicine Basis of Bone Tumors. In: Basic Principles of Nuclear
Medicine (1st edition), Eds. Abdelhamid El-Gazzar, Springer-Verlarg, New York.
8. Ibrahim EM. In: Textbook of Tropical Surgery. Eds. Refaat Kamel and John Lumley,
Westminister Publishing Ltd., London, 2004, Chapter 70.
9. Ibrahim EM, Al-Maghrabi J A. Basis of Tumor Imaging 1: Principles of Tumor Pathology and
Biology. In: Basic Principles of Nuclear Medicine (Second edition), Eds. Abdelhamid El-Gazzar,
Springer-Verlarg, New York, 2006, p 264-277.
10. Ibrahim EM, Ezzat AA. Cancer Control in Asia Pacific – Saudi Arabia
11. Ibrahim EM, Elkhodary A, Elgazzar AH. Nuclear Oncology 1: Principle of Tumor Pathology and
Biology. In: Basic Principles of Nuclear Medicine (2nd edition), Eds. Abdelhamid El-Gazzar,
Springer-Verlarg, New York, 2014, p 347-368.

List of Publications - January 2015

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

Similaire à List of Publications - January 2015

Similaire à List of Publications - January 2015 (20)

List of Publications - January 2015